移动卫生干预措施减少老年人坐着时间的有效性:系统审查和元分析
Siqing Chen1, Chenchen Wang2,3, Albert Ko4
1Department of Nursing, School of Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang Province, China.
Journal of medical Internet research
|May 9, 2025
概括
移动健康 (mHealth) 干预措施显著减少了老年人坐着的时间. 技术驱动的战略对改善这一人口群体的福祉和公共卫生工作具有前景.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 数字健康数字健康
背景情况:
- 在老年人中,久坐不动的行为正在增加,导致不良的健康结果.
- 移动健康 (mHealth) 干预提供了一种有希望的方法,可以提供健康信息并促进行为改变.
- 了解mHealth在减少老年人久坐时间方面的有效性至关重要.
研究的目的:
- 系统地审查和对移动健康干预措施在减少55岁及以上成年人坐着时间的有效性进行元分析.
- 确定关键的干预特征和与减少久坐行为相关的行为改变技术.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析,遵循PRISMA指南.
- 搜索了多个数据库 (PubMed,Embase,科学网,Cochrane) 到2023年10月.
- 使用Cochrane偏差风险 (ROB 2) 和MINORS工具评估研究质量;使用审查经理进行的元分析.
主要成果:
- 确定了10项研究,其中3项被纳入了元分析.
- mHealth干预措施显著减少了每天59.1分钟的久坐行为 (WMD = 59.1分钟/天,95%CI 99.1至20.2;P=.003).
- 干预通常使用智能手机,每天发生,持续12周,并采用诸如目标设定和行动计划等行为改变技术.
结论:
- 移动健康干预措施有效地减少了老年人坐着的时间.
- 具体的干预频率,持续时间,移动监测和行为改变技术提高了有效性.
- 移动健康是技术驱动的公共卫生倡议的一个有价值的工具,以促进老年人的福祉.
相关概念视频
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


